Author Archives: 8djs1

The Social Identification and Integration of Pharmaceutical Products

In ‘Depression and Consumption: Psychopharmaceuticals, Branding, and New Identity Practices,’ Nathan Greenslit suggests that the packaging, marketing and targeting of pharmaceutical products not only allows them to assume changing social lives, but allows them to represent various cultural messages that … Continue reading

Posted in Uncategorized | Leave a comment

Ads: Determining Consent Amongst Consumers

Jill Fisher is interested in the ways by which human subjects are introduced to the opportunity to participate in clinical trials, and how protected and informed those populations truly are. ‘Ready-to-Recruit’ or ‘Ready-to-Consent’ Populations? considers three case studies that exemplify … Continue reading

Posted in Uncategorized | Leave a comment

Globalized Implications

Adriana Petryna extends the conversation about clinical research trials unto a more globalized context and analysis. Contract research organizations are increasingly present in Eastern European and Central American societies. In an effort to recruit extensive population samples for clinical trials, … Continue reading

Posted in Uncategorized | Leave a comment

RCT’s

“The Randomized Controlled Trial: Gold Standard, or Merely Standard” begins by emphasizing the popularity of randomized controlled trials (RCT’s) over other types of research designs. Consequently, RCT’s are the easiest to obtain funding, and, though they are problematic in many … Continue reading

Posted in Uncategorized | Leave a comment

Week Seven Summary

In Corporate Science and the Husbandry of Scientific and Medical Knowledge by the Pharmaceutical Industry, Alastair Matheson expresses an interest into the process by which scientific and medical knowledge becomes constructed, and how this supposedly truth oriented knowledge might be … Continue reading

Posted in Uncategorized | Leave a comment

Marketization of Medicine

Elliot begins by defining the concept of ‘detailing’ doctors, and acknowledges how the pharmaceutical sales force in America doubled from 1996-2001. Since the first theoretical ‘duty’ of doctors is, according to Elliot, to their patients, the question arises as to … Continue reading

Posted in Uncategorized | Leave a comment

The Ethical Contention of Gift Giving

By considering the articles assigned, two specific questions come to mind. Firstly, is it unethical for physicians to receive gifts from the pharmaceutical industry, and, secondly, what is a reasonable response to this seemingly contested issue? Thompson elucidates what specifically … Continue reading

Posted in Uncategorized | Leave a comment